---
title: "BriaCell wins FDA clearance to start Bria-PROS+ prostate cancer trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294958905.md"
description: "BriaCell Therapeutics has received FDA clearance for its Bria-PROS+ Investigational New Drug (IND) application, permitting the initiation of a Phase 1/2a clinical trial for prostate cancer. This development follows the program's prior acquisition of a $2 million non-dilutive grant from the US National Cancer Institute."
datetime: "2026-08-05T11:30:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294958905.md)
  - [en](https://longbridge.com/en/news/294958905.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294958905.md)
---

# BriaCell wins FDA clearance to start Bria-PROS+ prostate cancer trial

-   BriaCell won FDA clearance for its Bria-PROS+ IND, allowing a Phase 1/2a prostate cancer study to proceed. \* The program previously secured a USD 2 million non-dilutive grant from the US National Cancer Institute. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Briacell Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608050730PRIMZONEFULLFEED9803903) on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [BCTXW.US](https://longbridge.com/en/quote/BCTXW.US.md)
- [BCTX.US](https://longbridge.com/en/quote/BCTX.US.md)
- [BCTXZ.US](https://longbridge.com/en/quote/BCTXZ.US.md)
- [BCTXL.US](https://longbridge.com/en/quote/BCTXL.US.md)

## Related News & Research

- [Candel Therapeutics Eyes 2026 Prostate Cancer Filing as Lung Study Ramps Up](https://longbridge.com/en/news/295693213.md)
- [Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | CADL Stock News](https://longbridge.com/en/news/295797039.md)
- [Granite-Integral co-leads $34 million Series D financing in Craif](https://longbridge.com/en/news/296226716.md)
- [10:30 ETCancer Diagnostics Market worth $44.92 billion by 2031 - Exclusive Report by MarketsandMarkets™](https://longbridge.com/en/news/296121121.md)
- [06:05 ETRyboDyn Unveils a Hidden Human Proteome and a New Universe of Actionable Cancer Targets](https://longbridge.com/en/news/295646300.md)